These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 30851393)

  • 1. Polymer-lipid hybrid nanoparticles: A novel drug delivery system for enhancing the activity of Psoralen against breast cancer.
    Du M; Ouyang Y; Meng F; Zhang X; Ma Q; Zhuang Y; Liu H; Pang M; Cai T; Cai Y
    Int J Pharm; 2019 Apr; 561():274-282. PubMed ID: 30851393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of psoralen polymer-lipid hybrid nanoparticles and their reversal of multidrug resistance in MCF-7/ADR cells.
    Huang Q; Cai T; Li Q; Huang Y; Liu Q; Wang B; Xia X; Wang Q; Whitney JCC; Cole SPC; Cai Y
    Drug Deliv; 2018 Nov; 25(1):1056-1066. PubMed ID: 29695174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fabrication of psoralen-loaded lipid-polymer hybrid nanoparticles and their reversal effect on drug resistance of cancer cells.
    Yuan Y; Chiba P; Cai T; Callaghan R; Bai L; Cole SPC; Cai Y
    Oncol Rep; 2018 Aug; 40(2):1055-1063. PubMed ID: 29901161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening of metabolites in the treatment of liver cancer xenografts HepG2/ADR by psoralen-loaded lipid nanoparticles.
    Li L; Zou T; Liang M; Mezhuev Y; Tsatsakis AM; Đorđević AB; Lan M; Liu F; Cai T; Gong P; Cai Y
    Eur J Pharm Biopharm; 2021 Aug; 165():337-344. PubMed ID: 34062256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psoralen-loaded lipid-polymer hybrid nanoparticles enhance doxorubicin efficacy in multidrug-resistant HepG2 cells.
    Yuan Y; Cai T; Callaghan R; Li Q; Huang Y; Wang B; Huang Q; Du M; Ma Q; Chiba P; Cai Y
    Int J Nanomedicine; 2019; 14():2207-2218. PubMed ID: 30988617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymeric Lipid Hybrid Nanoparticles as a Delivery System Enhance the Antitumor Effect of Emodin in Vitro and in Vivo.
    Liu H; Zhuang Y; Wang P; Zou T; Lan M; Li L; Liu F; Cai T; Cai Y
    J Pharm Sci; 2021 Aug; 110(8):2986-2996. PubMed ID: 33864779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholate-modified polymer-lipid hybrid nanoparticles for oral delivery of quercetin to potentiate the antileukemic effect.
    Yin J; Hou Y; Song X; Wang P; Li Y
    Int J Nanomedicine; 2019; 14():4045-4057. PubMed ID: 31213814
    [No Abstract]   [Full Text] [Related]  

  • 8. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
    Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D
    Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tailored polymer-lipid hybrid nanoparticles for the delivery of drug conjugate: dual strategy for brain targeting.
    Agrawal U; Chashoo G; Sharma PR; Kumar A; Saxena AK; Vyas SP
    Colloids Surf B Biointerfaces; 2015 Feb; 126():414-25. PubMed ID: 25601092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. iRGD-modified lipid-polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability.
    Gao F; Zhang J; Fu C; Xie X; Peng F; You J; Tang H; Wang Z; Li P; Chen J
    Int J Nanomedicine; 2017; 12():4147-4162. PubMed ID: 28615942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gelatin coated hybrid lipid nanoparticles for oral delivery of amphotericin B.
    Jain S; Valvi PU; Swarnakar NK; Thanki K
    Mol Pharm; 2012 Sep; 9(9):2542-53. PubMed ID: 22845020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid-Polymer Hybrid Nanoparticles Synthesized via Lipid-Based Surface Engineering for a robust drug delivery platform.
    Soomherun N; Kreua-Ongarjnukool N; Niyomthai ST; Chumnanvej S
    Colloids Surf B Biointerfaces; 2024 May; 237():113858. PubMed ID: 38547797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
    Li C; Ge X; Wang L
    Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysozyme-loaded lipid-polymer hybrid nanoparticles: preparation, characterization and colloidal stability evaluation.
    Devrim B; Kara A; Vural İ; Bozkır A
    Drug Dev Ind Pharm; 2016 Nov; 42(11):1865-76. PubMed ID: 27091346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functionalized Lipid-Polymer Hybrid Nanoparticles Mediated Codelivery of Methotrexate and Aceclofenac: A Synergistic Effect in Breast Cancer with Improved Pharmacokinetics Attributes.
    Garg NK; Tyagi RK; Sharma G; Jain A; Singh B; Jain S; Katare OP
    Mol Pharm; 2017 Jun; 14(6):1883-1897. PubMed ID: 28402673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan-functionalized lipid-polymer hybrid nanoparticles for oral delivery of silymarin and enhanced lipid-lowering effect in NAFLD.
    Liang J; Liu Y; Liu J; Li Z; Fan Q; Jiang Z; Yan F; Wang Z; Huang P; Feng N
    J Nanobiotechnology; 2018 Sep; 16(1):64. PubMed ID: 30176941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid-chitosan hybrid nanoparticles for controlled delivery of cisplatin.
    Khan MM; Madni A; Torchilin V; Filipczak N; Pan J; Tahir N; Shah H
    Drug Deliv; 2019 Dec; 26(1):765-772. PubMed ID: 31357896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved oral delivery of tilianin through lipid-polymer hybrid nanoparticles to enhance bioavailability.
    Zeng C; Zheng R; Yang X; Du Y; Xing J; Lan W
    Biochem Biophys Res Commun; 2019 Nov; 519(2):316-322. PubMed ID: 31506175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
    Yu JM; Li YJ; Qiu LY; Jin Y
    J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient delivery of antitumor drug to the nuclei of tumor cells by amphiphilic biodegradable poly(L-aspartic acid-co-lactic acid)/DPPE co-polymer nanoparticles.
    Han S; Liu Y; Nie X; Xu Q; Jiao F; Li W; Zhao Y; Wu Y; Chen C
    Small; 2012 May; 8(10):1596-606. PubMed ID: 22411637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.